If you’ve injected your weight-loss medication in an airport bathroom, you’re not alone. Or maybe you decided to skip your vacation altogether to avoid the hassle. Research from Levity, a digital ...

Automated insulin delivery developer ViCentra aims to show why its option is unique in a space led by longtime fixtures. The Dutch medtech company is rolling out its Kaleido automated insulin patch ...

For the growing number of children with type 1 diabetes, the daily burden of managing their challenging chronic disease and maintaining good blood glucose control affects every aspect of their lives ...

Clinical research shows whey protein could play a role in controlling post-meal blood sugar spikes in women with gestational diabetes.

Crinetics’ PALSONIFY wins FDA approval as a new oral treatment for acromegaly, offering rapid, effective symptom control.

Background Postoperative cerebral infarction following coronary artery bypass grafting (CABG) for multivessel coronary artery disease (CAD) is a major complication and is associated with insulin ...

Vertex faces pressure from potential U.S. drug pricing reforms and tariffs. Click here to find out why VRTX stock is a Hold.

Arecor Therapeutics announced today that it signed a co-development with Sequel Med Tech to pair their diabetes offerings.

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even for those who eat healthily and exercise regularly. … ...

French drugmaker Sanofi said on Friday it would offer a month's supply of any of its insulin products for $35 to all patients in the U.S. with a valid prescription, regardless of insurance status.

If approved, Awiqli would become the first once-weekly basal insulin available in the United States for adults with Type 2 diabetes.

Sanofi plans to make insulin more affordable and accessible for all patients next year. The company has taken action to fix insulin prices at $35 ...